PI4KIIIβ is a therapeutic target in chromosome 1q–amplified lung adenocarcinomaXiaochao Tan, Jonathan M. Kurie, Carmen Behrens et al.|Science Translational Medicine|2020Cited by 68
Analysis of phosphatases in ER-negative breast cancers identifies DUSP4 as a critical regulator of growth and invasionAbhijit Mazumdar, Powel H. Brown|Breast Cancer Research and Treatment|2016Cited by 50
Blockade of AP-1 Potentiates Endocrine Therapy and Overcomes ResistanceLuca Malorni, Rachel Schiff, Chad J. Creighton et al.|Molecular Cancer Research|2016Cited by 49
The phosphatase PPM1A inhibits triple negative breast cancer growth by blocking cell cycle progressionAbhijit Mazumdar, Powel H. Brown|npj Breast Cancer|2019Cited by 47
P4-01-18: AP-1 Blockade Potentiates the Anti-Tumor Effect of Endocrine Treatment and Reverts the Resistant Phenotype in Hormone Receptor-Positive Breast Cancer.Livia Malorni, Rachel Schiff, Mario Giuliano et al.|Cancer Research|2011Cited by 1